Phase
Condition
Schizotypal Personality Disorder (Spd)
Autism
Tourette's Syndrome
Treatment
N/AClinical Study ID
Ages > 18 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
For FEP:
Diagnosis as assessed using DSM-IV of one of the following: schizophrenia,schizophreniform psychosis, psychosis not otherwise specified (NOS), briefpsychosis, schizoaffective syndrome, delusional disorder
First exposure to anti-psychotic medication less than 4 weeks prior to inclusion
Exclusion
Exclusion Criteria:
For FEP:
- Other dominant psychiatric illness deemed to be related to current psychoticsymptoms
For HC:
A history of diagnosis of a major psychiatric disorder, including substance usedisorders.
Family history of psychotic disorders in first degree relatives.
For all:
Evidence based on medical history, clinical signs, MRI or laboratory tests ofclinically significant somatic disorder, or previous disorder with brain engagement (e.g. tumour, neuroinflammatory disease, epilepsy) or significant brain trauma.
Exposure to an effective radiation dose of 25 mSv during the past year.
Pregnancy, lactating or breastfeeding (women).
Meets diagnostic criteria of substance use disorder (excluding nicotine dependence)as assessed using DSM-IV or as determined using repeated positive urine screensduring the course of the study.
Metallic object in the eye, or ferro/electromagnetic implants. History ofclaustrophobic anxiety during MRI.
Symptoms of severe bacterial, fungal, or viral infection (including upperrespiratory tract infection), with systemic effects as detected by e.g. fever,within 7 days prior to inclusion.
Treatment with any antihemostatic medication within 2 weeks of lumbar puncture andarterial line placement of either the baseline or 1 year follow-up.
Blood donation (1 unit or more) within 90 days prior to Screening, plasma donationfrom 1 week prior to Screening, and platelet donation from 6 weeks prior toinclusion.
Other unspecified reasons that, in the opinion of the Investigator or the Sponsor,make the participant unsuitable for enrollment. This may include very high symptomseverity or signs of aggressiveness and hostility.
Study Design
Study Description
Connect with a study center
SLSO Psykiatri Stockholm in collaboration w Karolinska Institutet
Stockholm,
SwedenActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.